Category: Diagnostics

Home
Life Sciences
Diagnostics

A molecular bridge connecting a financial symbol (or insurance card) to a precisely focused biomarker icon and a patient silhouette, illustrating the successful legislative efforts to expand insurance coverage for biomarker testing, paving the way for personalized medicine.

New York’s New Biomarker Testing Insurance Coverage: Your Rights Explained

Philip Crowley July 25, 2023

Improvements to New York Health Insurance: Biomarker Testing Testing for biomarkers in patients is the state of the art in

Futuristic pacemaker in clinical setting symbolizing FDA IDE process

FDA Investigational Device Exemption (IDE) Process:
Requirements & Application Guide

Philip Crowley August 4, 2021

Demystifying the FDA Investigational Device Exemption (IDE) Process The journey to bring a new medical device to market is a

Legal document with approved stamp on wooden desk symbolizing FDA IND application review and regulatory approval process

FDA IND Process Guide:
Legal Guidance & Common Mistakes

Philip Crowley June 28, 2021

Why the IND Process Matters Drug sponsors face a long and winding road from discovery to market. A critical step